The Prague Post - US panel weighs authorizing Covid vaccines for youngest children

EUR -
AED 4.114203
AFN 72.817493
ALL 91.806753
AMD 403.050176
ANG 2.005697
AOA 1028.410237
ARS 1700.02381
AUD 1.609691
AWG 2.01649
AZN 1.908101
BAM 1.956538
BBD 2.25478
BDT 137.891994
BGN 1.885913
BHD 0.422157
BIF 3362.252772
BMD 1.120272
BND 1.433134
BOB 13.433005
BRL 5.624437
BSD 1.119437
BTN 108.26534
BWP 15.476043
BYN 3.433195
BYR 21957.339284
BZD 2.251479
CAD 1.597575
CDF 2593.430659
CHF 0.933297
CLF 0.027718
CLP 1094.449915
CNY 7.510923
CNH 7.509281
COP 3639.148918
CRC 511.090432
CUC 1.120272
CUP 26.867131
CVE 110.3061
CZK 24.416559
DJF 199.347836
DKK 7.474486
DOP 67.485145
DZD 150.697652
EGP 58.66519
ERN 16.804086
ETB 180.823716
FJD 2.52095
FKP 0.843776
GBP 0.84794
GEL 2.907139
GGP 0.843776
GHS 13.23193
GIP 0.843776
GMD 82.900102
GNF 9848.669605
GTQ 8.550186
GYD 234.137239
HKD 8.791108
HNL 30.051734
HRK 7.534391
HTG 146.591348
HUF 365.897753
IDR 20051.755911
ILS 3.441698
IMP 0.843776
INR 108.431015
IQD 1468.116997
IRR 1940479.859557
ISK 136.975965
JEP 0.843776
JMD 177.839438
JOD 0.794279
JPY 177.189016
KES 145.48982
KGS 97.96614
KHR 4557.596449
KMF 492.919592
KPW 1008.245527
KRW 1499.159786
KWD 0.347688
KYD 0.932952
KZT 500.408685
LAK 25103.46557
LBP 100297.5301
LKR 370.369652
LRD 191.431327
LSL 18.687246
LTL 3.307873
LVL 0.677642
LYD 7.191808
MAD 11.16376
MDL 19.937518
MGA 4991.949116
MKD 61.598226
MMK 2352.228864
MNT 4029.60935
MOP 9.049372
MRU 44.822701
MUR 53.078339
MVR 17.263624
MWK 1941.157929
MXN 20.134634
MYR 4.578553
MZN 71.596144
NAD 18.687246
NGN 1489.301003
NIO 41.248356
NOK 10.718593
NPR 173.227637
NZD 1.999216
OMR 0.430749
PAB 1.119417
PEN 3.853653
PGK 4.986613
PHP 70.333502
PKR 310.010544
PLN 4.377969
PYG 6531.550256
QAR 4.081421
RON 5.354122
RSD 117.495256
RUB 95.784159
RWF 1653.445591
SAR 4.205092
SBD 8.962753
SCR 15.683224
SDG 673.842448
SEK 11.197077
SGD 1.434151
SHP 0.847568
SLE 27.637535
SLL 23491.543258
SOS 639.749792
SRD 42.425796
STD 23187.377117
STN 24.730014
SVC 9.795694
SYP 14565.782192
SZL 18.619248
THB 37.684287
TJS 10.33255
TMT 3.932156
TND 3.3625
TOP 2.697347
TRY 55.134316
TTD 7.593863
TWD 35.705991
TZS 2951.918227
UAH 50.231213
UGX 4561.699685
USD 1.120272
UYU 44.897129
UZS 13203.978722
VES 978.71339
VND 29095.715097
VUV 134.637042
WST 3.119636
XAF 655.957
XAG 0.018629
XAU 0.000271079447
XCD 3.027592
XCG 2.017561
XDR 0.792091
XOF 655.957
XPF 119.331742
YER 264.604108
ZAR 18.639148
ZMK 10083.789562
ZMW 22.266694
ZWL 360.72726
SSP 6439.035069
MXV 2.275704
  • RBGPF

    4.0900

    68.14

    +6%

  • CMSC

    -0.3900

    19.73

    -1.98%

  • RYCEF

    -0.6000

    18.8

    -3.19%

  • GSK

    0.4200

    47.02

    +0.89%

  • RIO

    -2.7300

    93.16

    -2.93%

  • BTI

    0.8900

    53.9

    +1.65%

  • BP

    -0.5000

    44.51

    -1.12%

  • BCE

    0.0100

    19.76

    +0.05%

  • NGG

    -0.7400

    76.11

    -0.97%

  • AZN

    1.5100

    160.12

    +0.94%

  • VOD

    0.2600

    16.79

    +1.55%

  • BCC

    -2.5300

    72.92

    -3.47%

  • RELX

    0.4900

    34.52

    +1.42%

  • CMSD

    -0.4700

    19.86

    -2.37%

  • JRI

    -0.1400

    10.49

    -1.33%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: Frederic J. BROWN - AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

J.Simacek--TPP